EnteroTrack, LLC provides the Esophageal String Test (EST) using its EnteroTracker device, offering a minimally invasive, non-endoscopic tool for clinicians to collect upper gastrointestinal samples and monitor Eosinophilic Esophagitis (EoE) activity in patients. The office-based procedure helps assess mucosal inflammation and biomarkers over time, potentially reducing the need for repeated endoscopies.
Subscribe to see EnteroTrack, LLC’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
EnteroTrack, LLC is a medical device company headquartered in Aurora, United States. It has raised at least $6.7M across the 2 funding rounds on record. Its most recent funding round raised $2M in September 2026. Xcout tracks 7 named people at EnteroTrack, LLC, including Robin Shandas (Chief Executive Officer (CEO)).
As of 20 November 2026. Source: Xcout Intel.
1 more named person on record for EnteroTrack, LLC, with roles, board committees and tenure — see the full roster →
At least $6.7M raised across the 2 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $2M | — | |
| SEC Form D filing | $4.7M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
A few of EnteroTrack, LLC's closest competitors — see the full list of competitors and alternatives →
The Reflux Company provides patient-centered diagnostic and therapeutic solutions for individuals suffering from gastroesophageal reflux. The company offers a portfolio of FDA-cleared products, including the Restech Dx-pH upper airway test, the Stretta incision-free procedure for chronic GERD, the Reflux Band nighttime sleep device, and the at-home PepsinCheck saliva test.
Origin Sciences is a medical technology company based in the UK that develops innovative devices and tests to aid in the detection and diagnosis of gastrointestinal diseases.
BiBB Instruments AB is a medical technology company that develops and manufactures EndoDrill®, a patented series of motorized endoscopic biopsy instruments designed to improve cancer diagnostics. The system uses an electric rotating needle technology to obtain high-quality core tissue samples during ultrasound-guided endoscopic procedures for various cancers, including gastrointestinal, lung, and urological malignancies.
Lucid Diagnostics Inc. is a commercial-stage medical technology firm focused on diagnostic solutions. The company's primary objective is to serve patients afflicted with gastroesophageal reflux disease (GERD), commonly referred to as chronic heartburn or acid reflux, especially those at increased risk of developing precancerous esophageal conditions or the particularly aggressive esophageal adenocarcinoma. Their key product offerings include EsoGuard, an internally developed esophageal DNA test, and EsoCheck, a specialized device designed for collecting esophageal cells. Formed in 2018, Lucid Diagnostics Inc. has its headquarters in New York, New York, and operates as a subsidiary of PAVmed Inc.
PAVmed Inc. operates as a U.S.-based medical technology firm. Its principal commercialized products include CarpX, a percutaneous device designed to address carpal tunnel syndrome. Other key offerings are EsoCheck, an esophageal cell collection device vital for the early detection of esophageal adenocarcinoma and Barrett's Esophagus (BE), and EsoGuard, a specialized bisulfite-converted next-generation sequencing DNA assay. The company's extensive development pipeline further encompasses EsoCure, an esophageal ablation device intended to treat dysplastic BE; PortIO, an implantable intraosseous vascular access device; and NextFlo, a disposable infusion platform technology. Also in development are the Veris cancer healthcare platform, which features an intelligent vascular port for combined remote monitoring and data analytics, alongside Veris cardiac monitors. Additional innovations include NextVent single-use ventilators, FlexMO medical circulatory support cannulas, DisappEAR resorbable pediatric ear tubes, and Solys for noninvasive glucose monitoring. Established in 2014, the enterprise originally traded as PAXmed Inc. before rebranding to PAVmed Inc. in April 2015. Its corporate headquarters are located in New York, New York.
HarmonIQ Biosciences Inc. develops continuous hormone monitoring wearable technology using an aptamer-based sensing platform. The company provides real-time, science-driven hormone data to help consumers and biopharma users track their health, performance, and longevity.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Something wrong or missing about EnteroTrack, LLC? Suggest a correction · Work at EnteroTrack, LLC? Claim this profile
Post the link and the card appears automatically — each network fetches the image itself.